Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR

Objective: To investigate the reversal effect of tuberostemonine on MDR in myelogenous leukemia cells K562/ADR. Methods: Human myelogenous leukemia cells K562 and their adriamycin-resistance cells K562/ADR were used. The growth curve of cells treated by tuberostemonine and the Non-toxic concentratio...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Cancer
मुख्य लेखकों: Wang, Yu Jia, Zhao, Huan Dong, Zhu, Cai Feng, Li, Jian, Xie, Hong Juan, Chen, Yu Xiang
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Ivyspring International Publisher 2017
विषय:
Research Paper
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5436265/
https://ncbi.nlm.nih.gov/pubmed/28529625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.17688
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन